Digital Twin of the Aorta

Digital Twin of the Aorta

BioPharma Digital Twin of the Aorta The technology simulates blood flow so surgeons can test their approach before they operate. Scientists at Queen Mary University of London have created TAVR-AID, a digital twin of the aorta specific to each patient, which simulates...
Predicting responses to arthritis treatments

Predicting responses to arthritis treatments

BioPharma Predicting responses to arthritis treatments using machine learning Biological therapies can slow down the progression of rheumatoid arthritis. There are multiple drugs available – which one works best depends upon the patient’s genetics.  There...
Enhancing the efficacy of immunotherapy in lung cancer

Enhancing the efficacy of immunotherapy in lung cancer

BioPharma Enhancing the efficacy of immunotherapy in non-small cell lung cancer using an RGD-mimetic Queen Mary scientists led by Prof Kairbaan Hodivala-Dilke have invented a new methodology for treating lung cancer – the leading cause of cancer deaths...
A Combination Therapy for Neovascular Eye Diseases

A Combination Therapy for Neovascular Eye Diseases

BioPharma A Combination Therapy for Neovascular Eye Diseases Angiogenesis is a leading cause of eye problems among over 50s – including blindness. Conventional treatments have serious side effects, making them deeply unpleasant for patients. A new peptide therapy...
Reversing tumour resistance to kinase inhibitors

Reversing tumour resistance to kinase inhibitors

BioPharma Reversing tumour resistance to kinase inhibitors Drug resistance is behind most relapses in cancer patients. This is partly why anti-cancer drugs targeting oncogenic kinase signalling have failed to live up to expectations. Kinase inhibitors are only...